Growth hormone therapy may benefit protein metabolism in mitochondrial encephalomyopathy

Clinical Endocrinology

Volumn 47, Issue 1, 1997, Pages 113-117

  Carroll, P V ^a   Umpleby, A M ^a   Albany, E ^a   Jackson, N C ^a   Morgan Hughes, J A ^b   Sonksen, P H ^a   Russell Jones, D L ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CARNITINE; GROWTH HORMONE; RIBOFLAVIN; UBIQUINONE;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; ENCEPHALOMYOPATHY; HUMAN; MALE; MITOCHONDRIAL MYOPATHY; PRIORITY JOURNAL; PROTEIN METABOLISM; WEIGHT REDUCTION;

EID: 0030832257     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.2241031.x     Document Type: Article

References (19)

1. Bernsen, P.L., Gabreels, F.J., Ruitenbeek, W. & Hamburger, H.L. (1993) Treatment of complex I deficiency with riboflavin. Journal of the Neurological Sciences, 118(2), 181-187.
2. Clemmons, D.R., Smith-Banks, A. & Underwood, L.E. (1992) Reversal of diet-induced catabolism by infusion of recombinant IGF-I in humans. Journal of Clinical Endocrinology and Metabolism, 75, 234-238.
3. Fox, C. & Dunne, J. (1993) Corticosteroid responsive mitochondrial encephalomyopathy. Australian & New Zealand Journal of Medicine, 23(5), 522-523.
4. Guler, H.P., Zapf, J., Scheiwiller, E. & Froesch, E.R. (1988) Recombinant human IGF-I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proceedings of the National Academy of Science, USA, 85, 4889-4893.
5. Hammans, S.R., Sweeney, M.G., Brockington, M., Lennox, G.G., Lawton, N.F., Kennedy, C.R., Morgan-Hughes, J.A. & Harding, A.E. (1993) The mitochondrial DNA transfer RNA(Lys)A→G(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF). Relationship of clinical phenotype to proportion to mutant mitochondrial DNA. Brain, 116(3), 617-632.
6. Hammarquist, F., Stromberg, C., von der Decken, A., Vinnar, E. & Wernerman, J. (1992) Biosynthetic human growth hormone preserves both muscle protein synthesis and the decrease in muscle free glutamine, and improves whole body nitrogen economy after operation. Annals of Surgery, 216(2), 184-191.
7. Luft, R. (1994) The development of mitochondrial medicine. Proceedings of the National Academy of Sciences of the United States of America, 91(19), 8731-8738.
8. Matthews, D.E., Schwarz, D., Yang, R.D., Motil, K.J., Young, V.R. & Bier, D.M. (1982) Relationship of plasma leucine and α-ketoisocaproate during a 1-[1-13C]leucine infusion in man: a method for measuring human intracellular leucine tracer environment. Metabolism; Clinical and Experimental, 31, 1105-1112.
9. Mulligan, K., Grunfeld, C., Hellerstein, M.K., Neese, R.A. & Schambelan, M. (1993) Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. Journal of Clinical Endocrinology and Metabolism, 77(4), 956-962.
10. Reichmann, H. (1993) Therapy of metabolic myopathies. Nervenarzt, 64(10), 627-632.
11. Russell-Jones, D.L., Weissberger, A.J., Bowes, S.B., Kelly, J.M., Thomason, M., Umpleby, A.M., Jones, R.H. & Sönksen, P.H. (1993) The effects of growth hormone on protein metabolism in adult growth hormone deficient patients. Clinical Endocrinology, 38, 427-431.
12. Russell-Jones, D.L., Umpleby, A.M., Hennessy, T.R., Bowes, S.B., Shojaee-Moradie, F., Hopkins, K.D., Jackson, N.C., Kelly, J.M., Jones, R.H. & Sönksen, P.H. (1994) Use of a leucine clamp to demonstrate that IGF-1 actively stimulates protein synthesis in normal humans. American Journal of Physiology, 267, E591-E598.
13. Salomon, F., Cuneo, R.C., Hesp, R. & Sönksen, P.H. (1989) The effect of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine, 321, 1797-1803.
14. Schapira, A.H. (1994) Evidence for mitochondrial dysfunction in Parkinson's disease - a critical appraisal. Movement Disorders, 9(2), 125-138.
15. Teale, J.D. & Marks, V. (1990) Inappropriately elevated plasma insulin-like growth factor II in relation to suppressed insulin-like growth factor I in the diagnosis of non-islet cell tumor hypoglycaemia. Clinical Endocrinology, 33, 87-98.
16. Umpleby, A.M., Wiles, C.M., StJ Trend, P., Scobie, I.N., MacLeod, A.F., Spencer, G.T. & Sönksen, P.H. (1987) Protein turnover in acid maltase deficiency before and after treatment with a high protein diet. Journal of Neurology, Neurosurgery and Psychiatry, 50, 587-592.
17. Wallace, D.C., Lott, M.T., Shoffner, J.M. & Ballinger, S. (1994) Mitochondrial DNA mutations in epilepsy and neurological disease. Epilepsia, 35(Suppl 1), S43-S50.
18. Zeviani, M., Amati, P. & Savoia, A. (1994) Mitochondrial myopathies. Current Opinion in Rheumatology, 6(6), 559-567.
19. Zhu-Ming, J., Gui-Zhen, H.E., Si-Yuan, Z., Xiu-Rong, W., Nai-Fai, Y., Yu, Z. & Wilmore, D.W. (1989) Low dose growth hormone and hypocaloric nutrition attenuate the protein catabolic response after major operation. Annals of Surgery, 210(4), 513-523.